16m
Daily Maverick on MSNThe Global Fund will roll out the twice-yearly anti-HIV jab — with or without PepfarThe major backer of the lenacapavir roll-out is assuring nervous researchers that they will keep their part of funding ...
48m
Daily Maverick on MSNUS funding freeze puts vital tuberculosis research at risk as global health crisis loomsOne of the many projects that received termination letters is the Smart4TB programme. The project, coordinated by Johns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results